Skip to main content
. 2019 Jul 12;317(3):H617–H626. doi: 10.1152/ajpheart.00177.2019

Table 1.

Biochemical profile

Parameter Control DAAO Sac/Val Val Normal Range (Reference)
n 3 6 6 5
Sodium, mEq/L 191.8 ± 4.4 164.5 ± 4.4 177.7 ± 5.9 176.0 ± 9.9 141–149 (8a)
Potassium, mEq/L 4.8 ± 0.5 5.2 ± 0.3 5.3 ± 0.3 5.2 ± 0.3 5.2–7.8 (8a)
Chloride, mEq/L 144.8 ± 5.5 118.0 ± 4.0 132.7 ± 5.4 131.3 ± 10.6 102–109 (8a)
ALT, U/L 68.3 ± 11.5 60.3 ± 9.6 58.3 ± 7.4 96.8 ± 25.8 20–42 (8a)
AST, U/L 97.0 ± 18.2 165.2 ± 41.3 128.2 ± 30.9 223.6 ± 91.5 39–84 (8a)
Creatinine, mg/dL 0.3 ± 0.0 0.2 ± 0.0 0.5 ± 0.1** 0.3 ± 0.0 0.3–0.5 (4)
BUN, mg/dL 35.0 ± 3.0 34.3 ± 2.3 49.7 ± 3.7* 43.4 ± 4.9 16–23 (8a)

Values are means ± SE; n = no. of rats. Serum chemistry values of control (n = 3), d-amino acid oxidase (DAAO)-expressing rats (n = 6), and DAAO-expressing rats then treated with sacubitril/valsartan (Sac/Val; n = 6) or valsartan (Val; n = 5). ALT, alanine aminotransferase; AST, aspartate aminotransferase; BUN, blood urea nitrogen.

*

P < 0.05,

**

P < 0.01 for sacubitril/valsartan vs. DAAO, obtained by 1-way ANOVA with Šídák’s multiple-comparison test or Kruskal-Wallis test followed by Dunn’s multiple-comparison test.